Patents by Inventor Andreas Ochs
Andreas Ochs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10913698Abstract: A process for conducting exothermic equilibrium reactions, especially for the performance of methanol synthesis by heterogeneously catalysed conversion of synthesis gas, is proposed, which enables readjustment and hence optimization of the reaction conditions along the longitudinal coordinate of the reactor. For this purpose, in the process according to the invention, a reactor is used which is divided into a multitude of series-connected reaction cells, each of which comprises a preheating zone, a cooled reaction zone, one or more cooling zones and a deposition zone for condensable reaction products. In this way, the reaction conditions are adjustable to the respective, local composition of the reaction mixture and variable over the reactor length.Type: GrantFiled: April 26, 2018Date of Patent: February 9, 2021Assignee: L'Air Liquide Societe Anonyme Pour L'Etude Et L'Exploitation Des Procedes Georges ClaudeInventors: Frank Castillo-Welter, Stephane Haag, Robert Frind, Timm Schuhmann, Andreas Ochs, Marc Wagner, Solene Valentin
-
Patent number: 10898874Abstract: A reactor for conducting exothermic equilibrium reactions, especially for the performance of methanol synthesis by heterogeneously catalysed conversion of synthesis gas, is proposed, which enables readjustment and hence optimization of the reaction conditions along the longitudinal coordinate of the reactor. For this purpose, in accordance with the invention, the reactor is divided into a multitude of series-connected reaction cells, each of which comprises a preheating zone, a cooled reaction zone, one or more cooling zones and a deposition zone for condensable reaction products. In this way, the reaction conditions are adjustable to the respective, local composition of the reaction mixture and variable over the reactor length.Type: GrantFiled: April 26, 2018Date of Patent: January 26, 2021Assignee: L'Air Liquide Societe Anonyme Pour L'Etude Et L'Exploitation Des Procedes Georges ClaudeInventors: Frank Castillo-Welter, Stephane Haag, Robert Frind, Timm Schuhmann, Andreas Ochs, Marc Wagner, Solene Valentin
-
Publication number: 20200197890Abstract: A reactor for conducting exothermic equilibrium reactions, especially for the performance of methanol synthesis by heterogeneously catalysed conversion of synthesis gas, is proposed, which enables readjustment and hence optimization of the reaction conditions along the longitudinal coordinate of the reactor. For this purpose, in accordance with the invention, the reactor is divided into a multitude of series-connected reaction cells, each of which comprises a preheating zone, a cooled reaction zone, one or more cooling zones and a deposition zone for condensable reaction products. In this way, the reaction conditions are adjustable to the respective, local composition of the reaction mixture and variable over the reactor length.Type: ApplicationFiled: April 26, 2018Publication date: June 25, 2020Applicant: L'Air Liquide, Societe Anonyme pour l'Etude et l?Exploitation des Procedes Georges ClaudeInventors: Frank CASTILLO-WELTER, Stephane HAAG, Robert FRIND, Timm SCHUHMANN, Andreas OCHS, Marc WAGNER, Solene VALENTIN
-
Publication number: 20200199054Abstract: A process for conducting exothermic equilibrium reactions, especially for the performance of methanol synthesis by heterogeneously catalysed conversion of synthesis gas, is proposed, which enables readjustment and hence optimization of the reaction conditions along the longitudinal coordinate of the reactor. For this purpose, in the process according to the invention, a reactor is used which is divided into a multitude of series-connected reaction cells, each of which comprises a preheating zone, a cooled reaction zone, one or more cooling zones and a deposition zone for condensable reaction products. In this way, the reaction conditions are adjustable to the respective, local composition of the reaction mixture and variable over the reactor length.Type: ApplicationFiled: April 26, 2018Publication date: June 25, 2020Applicant: L'Air Liquide, Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges ClaudeInventors: Frank CASTILLO-WELTER, Stephane HAAG, Robert FRIND, Timm SCHUHMANN, Andreas OCHS, Marc WAGNER, Solene VALENTIN
-
Patent number: 9724620Abstract: In producing C2-C4 olefins, in particular propylene, from an educt mixture containing steam and oxygenates, such as methanol and/or dimethyl ether, the educt mixture is reacted in a reactor on a catalyst to a reaction mixture comprising low-molecular olefins and gasoline hydrocarbons, which in a first separating device is separated into a mixture rich in C5? olefins, a mixture rich in C5+ gasoline hydrocarbons, and an aqueous phase. To increase the yield of propylene the mixture rich in C5+ gasoline hydrocarbons is supplied to a second separating device, in which the aromatics contained in the mixture are separated. The residual stream largely free from aromatics is at least partly recirculated to the reactor.Type: GrantFiled: September 19, 2006Date of Patent: August 8, 2017Assignee: Lurgi GmbHInventors: Martin Rothaemel, Henning Buchold, Harald Kömpel, Andreas Glasmacher, Andreas Ochs
-
Patent number: 9028567Abstract: For producing synthetic fuels, an educt mixture containing steam and oxygenates, such as methanol and/or dimethyl ether, is converted to olefins on a catalyst in a first process stage, and this olefin mixture then is divided in a separating means into a stream rich in C1-C4 hydrocarbons and a stream rich in C5+ hydrocarbons. The stream rich in C5+ hydrocarbons is divided into a stream rich in C5 and C6 hydrocarbons and a stream rich in C7+ hydrocarbons, wherein the stream rich in C5 and C6 hydrocarbons is at least partly subjected to an etherification with methanol. The ethers thus obtained are admixed to the gasoline product stream.Type: GrantFiled: July 3, 2010Date of Patent: May 12, 2015Assignee: Lurgi GmbHInventors: Martin Rothaemel, Theis Ohlhaver, Peter Trabold, Andreas Ochs, Harald Koempel
-
Publication number: 20120102829Abstract: For producing synthetic fuels, an educt mixture containing steam and oxygenates, such as methanol and/or dimethyl ether, is converted to olefins on a catalyst in a first process stage, and this olefin mixture then is divided in a separating means into a stream rich in C1-C4 hydrocarbons and a stream rich in C5+ hydrcarbons. The stream rich in C5+ hydrocarbons is divided into a stream rich in C5 and C6 hydrocarbons and a stream rich in C7+ hydrocarbons, wherein the stream rich in C5 and C6 hydrocarbons is at least partly subjected to an etherification with methanol. The ethers thus obtained are admixed to the gasoline product stream.Type: ApplicationFiled: July 3, 2010Publication date: May 3, 2012Applicant: LURGI GMBHInventors: Martin Rothaemel, Theis Ohlhaver, Peter Trabold, Andreas Ochs, Harald Koempel
-
Patent number: 7759118Abstract: A composition which comprises an animal cell population which contains immature animal cells. The immature animal cells are characterized by expression of alpha-fetoprotein or lack of essential expression of alpha-fetoprotein and albumin, and at least a portion of said immature animal cells or at least a portion of the progeny of said immature animal cells is capable of differentiating into cells which express albumin. The cell population is cultured under conditions which result in expansion of the cells. Expansion of the cells may be achieved by culturing the cells in the presence of an extracellular matrix and liver stromal cells; and preferably in the presence of growth factors. Such cells may be used for liver transplantation, artificial livers, and for toxicology and pharmacology studies. Such cells may also be genetically engineered to express proteins or polypepetides of interest.Type: GrantFiled: January 12, 2007Date of Patent: July 20, 2010Assignee: Albert Einstein College of Medicine of Yeshiva UniversityInventors: Lola M. Reid, Maria Agelli, Andreas Ochs
-
Publication number: 20090124841Abstract: In producing C2-C4 olefins, in particular propylene, from an educt mixture containing steam and oxygenates, such as methanol and/or dimethyl ether, the educt mixture is reacted in a reactor on a catalyst to a reaction mixture comprising low-molecular olefins and gasoline hydrocarbons, which in a first separating device is separated into a mixture rich in C5? olefins, a mixture rich in C5+ gasoline hydrocarbons, and an aqueous phase. To increase the yield of propylene the mixture rich in C5+ gasoline hydrocarbons is supplied to a second separating device, in which the aromatics contained in the mixture are separated. The residual stream largely free from aromatics is at least partly recirculated to the reactor.Type: ApplicationFiled: September 19, 2006Publication date: May 14, 2009Inventors: Martin Rothaemel, Henning Buchold, Harald Kompel, Andreas Glasmacher, Andreas Ochs
-
Publication number: 20070134789Abstract: A composition which comprises an animal cell population which contains immature animal cells. The immature animal cells are characterized by expression of alpha-fetoprotein or lack of essential expression of alpha-fetoprotein and albumin, and at least a portion of said immature animal cells or at least a portion of the progeny of said immature animal cells is capable of differentiating into cells which express albumin. The cell population is cultured under conditions which result in expansion of the cells. Expansion of the cells may be achieved by culturing the cells in the presence of an extracellular matrix and liver stromal cells; and preferably in the presence of growth factors. Such cells may be used for liver transplantation, artificial livers, and for toxicology and pharmacology studies. Such cells may also be genetically engineered to express proteins or polypepetides of interest.Type: ApplicationFiled: January 12, 2007Publication date: June 14, 2007Inventors: Lola REID, Maria Agelli, Andreas Ochs
-
Publication number: 20040037814Abstract: A composition which comprises an animal cell population which contains immature animal cells. The immature animal cells are characterized by expression of alpha-fetoprotein or lack of essential expression of alpha-fetoprotein and albumin, and at least a portion of said immature animal cells or at least a portion of the progeny of said immature animal cells is capable of differentiating into cells which express albumin. The cell population is cultured under conditions which result in expansion of the cells. Expansion of the cells may be achieved by culturing the cells in the presence of an extracellular matrix and liver stromal cells; and preferably in the presence of growth factors. Such cells may be used for liver transplantation, artificial livers, and for toxicology and pharmacology studies. Such cells may also be genetically engineered to express proteins or polypepetides of interest.Type: ApplicationFiled: August 22, 2003Publication date: February 26, 2004Inventors: Lola M. Reid, Maria Agelli, Andreas Ochs
-
Publication number: 20010043919Abstract: A composition which comprises an animal cell population which contains immature animal cells. The immature animal cells are characterized by expression of alpha-fetoprotein or lack of essential expression of alpha-fetoprotein and albumin, and at least a portion of said immature animal cells or at least a portion of the progeny of said immature animal cells is capable of differentiating into cells which express albumin. The cell population is cultured under conditions which result in expansion of the cells. Expansion of the cells may be achieved by culturing the cells in the presence of an extracellular matrix and liver stromal cells; and preferably in the presence of growth factors. Such cells may be used for liver transplantation, artificial livers, and for toxicology and pharmacology studies. Such cells may also be genetically engineered to express proteins or polypepetides of interest.Type: ApplicationFiled: March 24, 2000Publication date: November 22, 2001Inventors: Lola M. Reid, Maria Agelli, Andreas Ochs
-
Patent number: 5789246Abstract: A composition which comprises an animal cell population, and which contains immature animal cells. The immature animal cells are characterized by expression of alpha-fetoprotein or lack of essential expression of alpha-fetoprotein and albumin, and at least a portion of said immature animal cells or at least a portion of the progeny of said immature cells is capable of differentiating into cells which express albumin. The cell population is cultured under conditions which result in expansion of the cells. Expansion of the cells may be achieved by culturing the cells in the presence of an extracellular matrix and liver stromal cells; and preferably in the presence of growth factors. Such cells may be used for liver transplantation, artificial livers, and for toxicology and pharmacology studies. Such cells may also be genetically engineered to express proteins or polypeptides of interest.Type: GrantFiled: November 18, 1996Date of Patent: August 4, 1998Assignee: Albert Einstein College of MedicineInventors: Lola M. Reid, Maria Agelli, Andreas Ochs
-
Patent number: 5576207Abstract: A composition which comprises an animal cell population, and which contains immature animal cells. The immature animal cells are characterized by expression of alpha-fetoprotein or lack of essential expression of alpha-fetoprotein and albumin, and at least a portion of said immature animal cells or at least a portion of the progeny of said immature cells is capable of differentiating into cells which express albumin. The cell population is cultured under conditions which result in expansion of the cells. Expansion of the cells may be achieved by culturing the cells in the presence of an extracellular matrix and liver stromal cells; and preferably in the presence of growth factors. Such cells may be used for liver transplantation, artificial livers, and for toxicology and pharmacology studies. Such cells may also be genetically engineered to express proteins or polypeptides of interest.Type: GrantFiled: June 24, 1994Date of Patent: November 19, 1996Assignee: Albert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva UniversityInventors: Lola M. Reid, Maria Agelli, Andreas Ochs